Genmab | GEN - Kısa Vadeli Yükümlülükler





Kısa Vadeli Yükümlülükler Değişiklik Tarih
Agios Pharmaceuticals USD 70.22M 11.37M 2026-06
Almirall EUR 323.65M 26.99M 2026-06
Amarin USD 175.14M 10.94M 2026-09
Amgen USD 25.5B 547M 2026-06
argenx SE USD 1.58B 254.81M 2026-06
AstraZeneca USD 31.27B 286M 2026-09
Bayer EUR 32.27B 1.19B 2026-06
BioMarin Pharmaceutical USD 1.6B 59.17M 2026-09
Demant DKK 12.42B 5B 2026-06
Exelixis USD 411.88M 49.95M 2026-09
Fresenius Medical Care EUR 7.18B 448.03M 2026-06
Genmab DKK 1.14B 38M 2026-06
GlaxoSmithKline GBP 20.72B 814M 2026-09
GN Store Nord DKK 5.97B 1.15B 2026-06
GRIFOLS EUR 2.3B 59M 2026-09
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Insmed USD 596.57M 157.83M 2026-09
Lakefront Biotherapeutics EUR 70.32M 30.1M 2026-06
Lonza CHF 3.57B 421M 2025-12
Merck EUR 8.12B 1.22B 2026-06
Novartis USD 32.52B 777M 2026-09
Regeneron Pharmaceuticals USD 6.2B 671.5M 2026-09
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 29.77B 2.16B 2026-09
UCB EUR 4.4B 470M 2025-12